Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amit Joshi

Showing results (331-340 of 455) with videos related to

Pageof 46
Sort By:
Indian Journal of Cancer|November 22, 2025
Vascular endothelial growth factor: A potential prognosticator in Ewing sarcomaGoutam Santosh Panda, Arun Chandrasekharan, Bharat Rekhi, et al.
Transplantation|May 5, 2025
Acute Response of Hepatocyte MRP2 Internalization as an Indicator of Ischemia-Reperfusion Injury in Liver TransplantationChristopher Monti, Seung-Keun Hong, Alice Lee, et al.
Oral Oncology|December 12, 2017
Results of a phase II randomized controlled clinical trial comparing efficacy of Cabazitaxel versus Docetaxel as second line or above therapy in recurrent head and neck cancerAmit Joshi, Vijay Patil, Vanita Noronha, et al.
JCO Global Oncology|January 27, 2023
National Cancer Grid Virtual Tumor Boards of Head and Neck Cancers: An Innovative Approach to Multidisciplinary CareShivakumar Thiagarajan, Vinisha Poojari, Vidisha Tuljapurkar, et al.
Ecancermedicalscience|August 3, 2022
Small cell carcinoma of the oesophagus: experience of an Indian Tertiary Cancer CentreGoutam Santosh Panda, Vanita Noronha, Subhash Yadav, et al.
International Journal of Radiation Oncology, Biology, Physics|March 29, 2024
Late Urinary Toxicity and Quality of Life With Pelvic Radiation Therapy for High-Risk Prostate Cancer: Dose-Effect Relations in the POP-RT Randomized Phase 3 TrialPriyamvada Maitre, Guncha Maheshwari, Joyita Sarkar, et al.
British Journal of Cancer|September 17, 2020
Prognostic and predictive significance of nuclear HIF1α expression in locally advanced HNSCC patients treated with chemoradiation with or without nimotuzumabUsha Patel, Manish Pandey, Sadhana Kannan, et al.
JTO Clinical and Research Reports|January 19, 2023
Clinical Profile, Practice Pattern, and Outcomes With First-Line Therapy in ALK-Positive Lung Cancer: Real-World Data From Resource-Constrained SettingsAkhil Kapoor, Vanita Noronha, Vijay Patil, et al.
Ecancermedicalscience|September 27, 2021
An observational study to evaluate factors predicting survival in patients of non-small cell lung cancer with poor performance status in resource-constrained settingsAkhil Kapoor, Vanita Noronha, Amit Joshi, et al.
Indian Journal of Cancer|June 21, 2014
Weekly chemotherapy as Induction chemotherapy in locally advanced head and neck cancer for patients ineligible for 3 weekly maximum tolerable dose chemotherapyVijay Maruti Patil, Vanita Noronha, Amit Joshi, et al.
Pageof 46

Showing results (331-340 of 455) with videos related to

Sort By:
Pageof 46
Indian Journal of Cancer|November 22, 2025
Vascular endothelial growth factor: A potential prognosticator in Ewing sarcomaGoutam Santosh Panda, Arun Chandrasekharan, Bharat Rekhi, et al.
Transplantation|May 5, 2025
Acute Response of Hepatocyte MRP2 Internalization as an Indicator of Ischemia-Reperfusion Injury in Liver TransplantationChristopher Monti, Seung-Keun Hong, Alice Lee, et al.
Oral Oncology|December 12, 2017
Results of a phase II randomized controlled clinical trial comparing efficacy of Cabazitaxel versus Docetaxel as second line or above therapy in recurrent head and neck cancerAmit Joshi, Vijay Patil, Vanita Noronha, et al.
JCO Global Oncology|January 27, 2023
National Cancer Grid Virtual Tumor Boards of Head and Neck Cancers: An Innovative Approach to Multidisciplinary CareShivakumar Thiagarajan, Vinisha Poojari, Vidisha Tuljapurkar, et al.
Ecancermedicalscience|August 3, 2022
Small cell carcinoma of the oesophagus: experience of an Indian Tertiary Cancer CentreGoutam Santosh Panda, Vanita Noronha, Subhash Yadav, et al.
International Journal of Radiation Oncology, Biology, Physics|March 29, 2024
Late Urinary Toxicity and Quality of Life With Pelvic Radiation Therapy for High-Risk Prostate Cancer: Dose-Effect Relations in the POP-RT Randomized Phase 3 TrialPriyamvada Maitre, Guncha Maheshwari, Joyita Sarkar, et al.
British Journal of Cancer|September 17, 2020
Prognostic and predictive significance of nuclear HIF1α expression in locally advanced HNSCC patients treated with chemoradiation with or without nimotuzumabUsha Patel, Manish Pandey, Sadhana Kannan, et al.
JTO Clinical and Research Reports|January 19, 2023
Clinical Profile, Practice Pattern, and Outcomes With First-Line Therapy in ALK-Positive Lung Cancer: Real-World Data From Resource-Constrained SettingsAkhil Kapoor, Vanita Noronha, Vijay Patil, et al.
Ecancermedicalscience|September 27, 2021
An observational study to evaluate factors predicting survival in patients of non-small cell lung cancer with poor performance status in resource-constrained settingsAkhil Kapoor, Vanita Noronha, Amit Joshi, et al.
Indian Journal of Cancer|June 21, 2014
Weekly chemotherapy as Induction chemotherapy in locally advanced head and neck cancer for patients ineligible for 3 weekly maximum tolerable dose chemotherapyVijay Maruti Patil, Vanita Noronha, Amit Joshi, et al.
Pageof 46